Search

Your search keyword '"Helin, K"' showing total 687 results

Search Constraints

Start Over You searched for: Author "Helin, K" Remove constraint Author: "Helin, K"
687 results on '"Helin, K"'

Search Results

2. Phonological skills in children acquiring Finnish at 3;6:the associations with lexical, auditory word recognition, and pre-reading skills

3. The role of natural gas in setting electricity prices in Europe

7. The methylation inhibitor 3DZNep promotes HDR pathway choice during CRISPR-Cas9 genome editing

8. Auditory word recognition ability in babble noise and phonological development in children at 3;6 years of age

22. Phonological development of Finnish speaking children at 3;6 and associations to previous and simultaneous lexical ability

23. BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers

29. PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells

32. The histone demethylase Jarid1b mediates angiotensin II‐induced endothelial dysfunction by controlling the 3'UTR of soluble epoxide hydrolase

33. Total cost of ownership analysis for modular final assembly systems.

34. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

35. Histone methylation-demethylation defects in forms of Intellectual Disability and Refractory Epilepsy

37. Isoform of Bruton's tyrosine kinase (BTK) protein

39. Isoform of bruton's tyrosine kinase (BTK) protein

41. Isoform of bruton's tyrosine kinase (BTK) protein

42. Btk inhibitors for use in treating chemotherapeutic drug-resistant epithelial tumours

44. COMPOSTI MODULATORI DELLA RESISTENZA FARMACOLOGICA IN CELLULE EPITELIALI TUMORALI

45. Analysis of KDM5C transcription: identification of new disease routes damaged in XLID/Epilepsy diseases

46. Finding new connections in the transcriptional regulation of Lysine-specific demethylase 5C (KDM5C) a disease gene involved in syndromic and non-syndromic XLID

47. Modulator compounds of the drug resistance in epithelial tumour cells

48. Btk inhibitors for use in treating chemotherapeutic drug-resistant epithelial tumours

49. COMPOSTI MODULATORI DELLA RESISTENZA FARMACOLOGICA IN CELLULE EPITELIALI TUMORALI

50. p65BTK targeting restores the apoptotic response to chemotherapy of p53-null drug-resistant colon cancer cells

Catalog

Books, media, physical & digital resources